Rullier E, Laurent C, Zerbib F, Belleannée G, Caudry M, Saric J
Service de chirurgie digestive, hôpital Saint-André, centre hospitalier universitaire de Bordeaux, France.
Ann Chir. 2000 Sep;125(7):618-24. doi: 10.1016/s0003-3944(00)00262-5.
Adenocarcinomas of the anorectal junction, especially T3 lesions, are usually treated by abdominoperineal resection. The aim of this study was to evaluate oncologic and functional results following conservative radiosurgical treatment of cancers of the anorectal junction.
From 1990 to 1999, among 395 patients with rectal carcinoma, 31 had sphincter-saving resection for a tumour located between 2 to 4.5 cm (mean 3.6) from the anal verge. There were 16 men and 15 women, mean age 62 years (range 30-86). There were 5 T2, 23 T3 and 3 T4 tumours; 17 were N1 and 3 were M1. Preoperative radiotherapy was performed in 26 patients (dose: 46 Gy, range: 36-54), with concomitant chemotherapy in 14 cases. Intersphincteric resection was performed six weeks after neoadjuvant treatment. Coloanal anastomoses were associated with a colonic pouch in 22 cases and with a protecting stoma in all cases.
There was no postoperative mortality. Seven complications occurred: 3 anastomotic fistulas, 3 pelvic haemorrhages and 1 acute pancreatitis. Three patients had a definitive stoma. After preoperative radiotherapy, down-staging (pT0-2 N0) occurred in 46% of cases (12/26). Distal margin was 2.2 cm (range: 1-3) and was microscopically safe in all cases. Lateral margin was safe (> or = 1 mm) in 97% of cases. With a mean follow-up of 36 months, no local recurrence was suspected. Twenty-six patients (84%) were alive, 23 free of disease. Half of the patients had perfect continence, whereas the other half had occasional minor soiling. Functional results were better in patients with a colonic pouch.
Conservative treatment of carcinomas of the anorectal junction is possible without compromising pelvic control and patient survival. Pelvic control was probably achieved by using preoperative radiotherapy with intersphincteric resection, ensuring safe distal and lateral margins.
肛管直肠交界腺癌,尤其是T3期病变,通常采用腹会阴联合切除术治疗。本研究旨在评估肛管直肠交界癌保守性放射外科治疗后的肿瘤学和功能结果。
1990年至1999年期间,在395例直肠癌患者中,31例因肿瘤位于距肛缘2至4.5厘米(平均3.6厘米)处而接受了保留括约肌的切除术。其中男性16例,女性15例,平均年龄62岁(范围30 - 86岁)。有5例T2期、23例T3期和3例T4期肿瘤;17例为N1期,3例为M1期。26例患者接受了术前放疗(剂量:46 Gy,范围:36 - 54),其中14例同时接受了化疗。新辅助治疗六周后进行括约肌间切除术。22例结肠肛管吻合术采用结肠袋,所有病例均有保护性造口。
无术后死亡病例。发生了7例并发症:3例吻合口瘘、3例盆腔出血和1例急性胰腺炎。3例患者有永久性造口。术前放疗后,46%(12/26)的病例出现降期(pT0 - 2 N0)。远端切缘为2.2厘米(范围:1 - 3)且所有病例镜下均安全。97%的病例侧切缘安全(≥1毫米)。平均随访36个月,未怀疑有局部复发。26例患者(84%)存活,23例无疾病。一半患者控便良好,另一半偶尔有轻微便污。采用结肠袋的患者功能结果更好。
肛管直肠交界癌的保守治疗是可行的,且不影响盆腔控制和患者生存。通过术前放疗联合括约肌间切除术可能实现盆腔控制,确保远端和侧切缘安全。